• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • Steen Solution™
    • PERFADEX® Plus
    • XVIVO
      Silicone Tubing Set™
    • XVIVO LS™ & XVIVO Disposable Lung Set™
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
    • Movies
  • Media
    • Videos
    • Webinars
  • About us
    • About Xvivo
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO Perfusion
  • Corporate
    • Corporate
    • The share
    • Press releases
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • CODE OF CONDUCT
    • Privacy policy
    • Subscribe
    • Thank you
    • Error
XVIVO Perfusion
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • Steen Solution™
    • PERFADEX® Plus
    • XVIVO
      Silicone Tubing Set™
    • XVIVO LS™ & XVIVO Disposable Lung Set™
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
    • Movies
  • Media
    • Videos
    • Webinars
  • About us
    • About Xvivo
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO Perfusion
  • Corporate
    • Corporate
    • The share
    • Press releases
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • CODE OF CONDUCT
    • Privacy policy
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
  • Press releases
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • CODE OF CONDUCT
  • Privacy policy
  • Subscribe
  • Thank you
  • Error

Financial Reports

Filter:
  • All
  • Interim reports
  • Annual Reports

2020

  • 2021-01-28Year-end ReportQ42020
  • 2021-01-28BokslutskommunikéQ42020
  • 2020-10-23Interim ReportQ32020
  • 2020-10-23KvartalsrapportQ32020
  • 2020-07-10KvartalsrapportQ22020
  • 2020-07-10Interim ReportQ22020
  • 2020-04-09Interim ReportQ12020
  • 2020-04-09KvartalsrapportQ12020

2019

  • 2020-03-09Årsredovisning2019
  • 2020-03-09Annual Report2019
  • 2020-01-30Year-end ReportQ42019
  • 2020-01-30BokslutskommunikéQ42019
  • 2019-10-24KvartalsrapportQ32019
  • 2019-10-24Interim ReportQ32019
  • 2019-07-12KvartalsrapportQ22019
  • 2019-07-12Interim ReportQ22019
  • 2019-04-24Interim ReportQ12019
  • 2019-04-24KvartalsrapportQ12019

2018

  • 2019-04-02Årsredovisning2018
  • 2019-04-02Annual Report2018
  • 2019-02-08BokslutskommunikéQ42018
  • 2019-02-08Year-end ReportQ42018
  • 2018-10-26Interim ReportQ32018
  • 2018-10-26KvartalsrapportQ32018
  • 2018-07-20KvartalsrapportQ22018
  • 2018-07-20Interim ReportQ22018
  • 2018-04-26Interim ReportQ12018
  • 2018-04-26KvartalsrapportQ12018

2017

  • 2018-04-04Årsredovisning2017
  • 2018-02-09Year-end ReportQ42017
  • 2018-02-09BokslutskommunikéQ42017
  • 2017-10-27KvartalsrapportQ32017
  • 2017-10-27Interim ReportQ32017
  • 2017-07-14Interim ReportQ22017
  • 2017-07-14KvartalsrapportQ22017
  • 2017-04-25Interim ReportQ12017
  • 2017-04-25KvartalsrapportQ12017

2016

  • 2017-04-04Årsredovisning2016
  • 2017-02-08Year-end ReportQ42016
  • 2017-02-08BokslutskommunikéQ42016
  • 2016-10-27KvartalsrapportQ32016
  • 2016-10-27Interim ReportQ32016
  • 2016-07-15Interim ReportQ22016
  • 2016-07-15KvartalsrapportQ22016
  • 2016-04-26KvartalsrapportQ12016
  • 2016-04-26Interim ReportQ12016

2015

  • 2016-04-11Årsredovisning2015
  • 2016-02-04BokslutskommunikéQ42015
  • 2016-02-04Year-end ReportQ42015
  • 2015-10-23Interim ReportQ32015
  • 2015-10-23KvartalsrapportQ32015
  • 2015-08-13Interim ReportQ22015
  • 2015-08-13KvartalsrapportQ22015
  • 2015-04-22KvartalsrapportQ12015
  • 2015-04-22Interim ReportQ12015

2014

  • 2015-03-31Årsredovisning2014
  • 2015-02-05BokslutskommunikéQ42014
  • 2015-02-05Year-end ReportQ42014
  • 2014-10-24Interim ReportQ32014
  • 2014-10-24KvartalsrapportQ32014
  • 2014-08-13Interim ReportQ22014
  • 2014-08-13KvartalsrapportQ22014
  • 2014-04-23KvartalsrapportQ12014
  • 2014-04-23Interim ReportQ12014

2013

  • 2014-04-07Årsredovisning2013
  • 2014-02-07Year-end ReportQ42013
  • 2014-02-07BokslutskommunikéQ42013
  • 2013-11-07Interim ReportQ32013
  • 2013-11-07KvartalsrapportQ32013
  • 2013-07-11KvartalsrapportQ22013
  • 2013-07-11Interim ReportQ22013
  • 2013-04-19KvartalsrapportQ12013
  • 2013-04-19Interim ReportQ12013

2012

  • 2013-04-15Årsredovisning2012
  • 2013-02-19Year-end ReportQ42012
  • 2013-02-19BokslutskommunikéQ42012
  • 2012-11-01KvartalsrapportQ32012
  • 2012-11-01Interim ReportQ32012
About us

XVIVO Perfusion is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivoperfusion.com

Newsletter

I have read and accepted XVIVO Perfusion's Privacy policy

*By signing up to our newsletter you consent to XVIVO Perfusion sending you our insights newsletter and occasional additional communications. Your personal data will be transfered to a third party newsletter distributor engaged by XVIVO Perfusion. All processing of your personal data is in compliance with the XVIVO Perfusion Privacy Policy. For more information on how we use your personal data, please read XVIVO Perfusion’s Privacy policy

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2021 XVIVO Perfusion. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO Perfusion. Read more about Cookies

Approve